How You Should Be Choosing Your Stocks

From Vantage Point | Ad

Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades. We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.

Click here now to join and get access to our forecasting.

INO Insider Trading (Inovio Pharmaceuticals)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $925,382.71

Inovio Pharmaceuticals Insider Trading History Chart

Inovio Pharmaceuticals Share Price & Price History

^$1.88

▼ -0.09 (-4.57%)

As of 05/20/2022 05:00 PM ET

Days: 30 | 90 | 365

Warning: The Last Value Play Gone After August?

From Oxford Club | Ad

In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward

Get the Details Now.

Inovio Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/16/2022	Simon X. Benito	Director	Sell	2,000	$3.16	$6,320.00
3/14/2022	David B Weiner	Director	Sell	4,083	$3.20	$13,065.60
1/19/2022	Simon X. Benito	Director	Sell	2,000	$4.27	$8,540.00
6/9/2021	Jacqueline Elizabeth Shea	COO	Sell	38,535	$10.01	$385,735.35	21,592
6/9/2021	Laurent Humeau	Insider	Sell	10,318	$9.07	$93,584.26	78,904
6/9/2021	Peter Kies	CFO	Sell	33,750	$10.01	$337,837.50	164,538
6/3/2021	Peter Kies	CFO	Sell	10,000	$8.03	$80,300.00	150,788
5/17/2021	Lota S. Zoth	Director	Sell	2,045	$6.62	$13,537.90	23,932
4/21/2021	David B. Weiner	Director	Sell	26,583	$8.57	$227,816.31	877,719
4/21/2021	Peter Kies	CFO	Sell	10,000	$8.52	$85,200.00	160,788
4/16/2021	Simon X. Benito	Director	Sell	2,000	$8.75	$17,500.00	53,650
3/26/2021	Jacqueline Elizabeth Shea	COO	Sell	4,710	$8.97	$42,248.70	72,084
3/16/2021	Simon X. Benito	Director	Sell	2,000	$10.41	$20,820.00
3/12/2021	Jacqueline Elizabeth Shea	COO	Sell	16,881	$10.06	$169,822.86	98,272
3/9/2021	David B Weiner	Director	Sell	7,000	$9.39	$65,730.00
2/3/2021	Jong Joseph Kim	CEO	Sell	62,500	$14.24	$890,000.00	1,078,313
2/1/2021	Jacqueline Elizabeth Shea	COO	Sell	28,336	$15.05	$426,456.80	66,871
2/1/2021	Jong Joseph Kim	CEO	Sell	100,000	$15.00	$1,500,000.00	1,078,313
1/28/2021	Jacqueline Elizabeth Shea	COO	Sell	16,713	$12.04	$201,224.52	34,296
1/15/2021	Peter Kies	CFO	Sell	30,000	$10.02	$300,600.00	149,290
12/15/2020	David B Weiner	Director	Sell	17,500	$10.71	$187,425.00	844,719
12/15/2020	Peter Kies	CFO	Sell	20,000	$10.69	$213,800.00	128,040
8/10/2020	Laurent Humeau	Insider	Sell	19,467	$19.06	$371,041.02	43,966
7/30/2020	Jong Joseph Kim	CEO	Sell	100,000	$21.13	$2,113,000.00	1,188,313
7/15/2020	Peter Kies	CFO	Sell	35,000	$24.95	$873,250.00	154,290
6/30/2020	Peter Kies	CFO	Sell	35,000	$26.50	$927,500.00	119,290
6/22/2020	Laurent Humeau	Insider	Sell	19,467	$14.70	$286,164.90	63,433
5/11/2020	David B Weiner	Director	Sell	2,404	$11.84	$28,463.36	827,219
3/12/2020	David B Weiner	Director	Sell	3,500	$11.14	$38,990.00	828,610
3/10/2020	David B Weiner	Director	Sell	3,500	$9.32	$32,620.00	828,610
1/13/2020	Jong Joseph Kim	CEO	Buy	22,500	$3.11	$69,975.00	1,100,707
8/30/2019	Laurent Humeau	Insider	Buy	4,500	$2.22	$9,990.00	50,333
8/1/2019	David B Weiner	Director	Sell	16,352	$2.72	$44,477.44	797,110
6/5/2019	Laurent Humeau	Insider	Buy	20,000	$2.50	$50,000.00	45,833
6/3/2019	Jong Joseph Kim	CEO	Sell	2,129,553	$2.36	$5,025,745.08	1,911,055
5/31/2019	Jong Joseph Kim	CEO	Sell	500,000	$2.44	$1,220,000.00	1,911,055
5/21/2019	Jong Joseph Kim	CEO	Sell	100,000	$3.31	$331,000.00	2,411,055

How You Should Be Choosing Your Stocks

From Vantage Point | Ad

Click here now to join and get access to our forecasting.

SEC Filings (Institutional Ownership Changes) for Inovio Pharmaceuticals (NASDAQ:INO)

43.28% of Inovio Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Inovio Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/18/2022	BNP Paribas Arbitrage SA	22,477	$81K	0.0%	-71.7%	0.010%
5/17/2022	Quantbot Technologies LP	57,000	$0.20M	0.0%	+10.0%	0.025%
5/17/2022	Royal Bank of Canada	45,342	$0.16M	0.0%	-69.8%	0.020%
5/16/2022	California State Teachers Retirement System	269,032	$0.97M	0.0%	-7.2%	0.121%
5/16/2022	Goldman Sachs Group Inc.	933,280	$3.35M	0.0%	-45.9%	0.421%
5/16/2022	State Street Corp	23,267,928	$83.53M	0.0%	+74.9%	10.491%
5/16/2022	Invesco Ltd.	218,103	$0.78M	0.0%	+173.0%	0.098%
5/16/2022	Smith Anglin Financial LLC	10,000	$36K	0.0%	N/A	0.005%
5/16/2022	UBS Group AG	1,640,012	$5.89M	0.0%	+99.3%	0.739%
5/16/2022	Hsbc Holdings PLC	47,672	$0.17M	0.0%	+15.7%	0.021%
5/13/2022	Renaissance Technologies LLC	393,881	$1.41M	0.0%	N/A	0.178%
5/13/2022	Northern Trust Corp	1,891,847	$6.79M	0.0%	-3.8%	0.853%
5/13/2022	Charles Schwab Investment Management Inc.	1,530,604	$5.50M	0.0%	+3.7%	0.690%
5/13/2022	American International Group Inc.	102,655	$0.37M	0.0%	-6.6%	0.046%
5/13/2022	Vanguard Group Inc.	11,247,922	$40.38M	0.0%	+1.9%	5.072%
5/12/2022	BlackRock Inc.	18,046,901	$64.79M	0.0%	-1.1%	8.137%
5/12/2022	Rhumbline Advisers	286,939	$1.03M	0.0%	-9.4%	0.129%
5/12/2022	Triatomic Management LP	235,000	$0.84M	0.7%	N/A	0.106%
5/12/2022	Metropolitan Life Insurance Co NY	13,431	$48K	0.0%	-71.6%	0.006%
5/12/2022	MetLife Investment Management LLC	114,358	$0.41M	0.0%	+56.5%	0.052%
5/12/2022	Capital Fund Management S.A.	105,738	$0.38M	0.0%	N/A	0.048%
5/12/2022	E Fund Management Co. Ltd.	83,306	$0.30M	0.0%	+191.6%	0.038%
5/12/2022	Citigroup Inc.	316,492	$1.14M	0.0%	-58.7%	0.143%
5/12/2022	Running Point Capital Advisors LLC	10,000	$36K	0.0%	N/A	0.005%
5/12/2022	Oppenheimer & Co. Inc.	58,347	$0.21M	0.0%	+140.7%	0.026%
5/11/2022	JPMorgan Chase & Co.	3,440,819	$12.35M	0.0%	-9.4%	1.551%
5/11/2022	WINTON GROUP Ltd	41,156	$0.15M	0.0%	+30.4%	0.019%
5/11/2022	GSA Capital Partners LLP	97,040	$0.35M	0.0%	+76.6%	0.044%
5/10/2022	ProShare Advisors LLC	60,540	$0.22M	0.0%	-19.1%	0.027%
5/10/2022	Mirae Asset Global Investments Co. Ltd.	28,739	$0.10M	0.0%	+93.1%	0.013%
5/9/2022	Swiss National Bank	497,500	$1.79M	0.0%	+7.5%	0.224%
5/9/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	44,845	$0.16M	0.0%	+12.3%	0.020%
5/9/2022	Qube Research & Technologies Ltd	24,738	$89K	0.0%	-71.6%	0.011%
5/4/2022	Advisor Group Holdings Inc.	157,239	$0.63M	0.0%	+17.9%	0.071%
5/2/2022	National Asset Management Inc.	30,815	$0.11M	0.0%	-21.4%	0.014%
4/29/2022	SG Americas Securities LLC	30,407	$0.11M	0.0%	-46.5%	0.014%
4/29/2022	Daiwa Securities Group Inc.	20,935	$75K	0.0%	+43.5%	0.009%
4/28/2022	DekaBank Deutsche Girozentrale	61,100	$0.22M	0.0%	+10.1%	0.028%
4/26/2022	Hennion & Walsh Asset Management Inc.	345,567	$1.24M	0.1%	+25.8%	0.156%
4/19/2022	Green Alpha Advisors LLC	79,182	$0.28M	0.2%	+9.0%	0.036%
4/12/2022	Brookstone Capital Management	18,585	$59K	0.0%	N/A	0.008%
4/6/2022	Cedar Brook Financial Partners LLC	88,750	$0.32M	0.1%	+62.8%	0.040%
3/17/2022	American Trust	22,166	$0.11M	0.0%	N/A	0.011%
3/9/2022	Norges Bank	1,402,804	$7M	0.0%	N/A	0.667%
2/23/2022	Barclays PLC	250,969	$1.25M	0.0%	+194.3%	0.119%
2/23/2022	BlackRock Inc.	18,244,914	$91.04M	0.0%	-0.7%	8.672%
2/19/2022	Wells Fargo & Company MN	241,972	$1.21M	0.0%	+23.7%	0.115%
2/16/2022	Deutsche Bank AG	135,512	$0.68M	0.0%	+5.2%	0.064%
2/16/2022	California State Teachers Retirement System	289,812	$1.45M	0.0%	+2.7%	0.138%
2/16/2022	Parametric Portfolio Associates LLC	136,064	$0.68M	0.0%	+3.4%	0.065%
2/16/2022	Wasatch Advisors Inc.	4,926,125	$24.58M	0.1%	+37.3%	2.341%
2/15/2022	Parametrica Management Ltd	16,183	$81K	0.1%	+55.0%	0.008%
2/15/2022	MetLife Investment Management LLC	73,073	$0.37M	0.0%	+21.5%	0.035%
2/15/2022	Seven Eight Capital LP	196,351	$0.98M	0.2%	-42.7%	0.093%
2/15/2022	Stifel Financial Corp	30,396	$0.15M	0.0%	-15.3%	0.014%
2/15/2022	Schonfeld Strategic Advisors LLC	37,500	$0.19M	0.0%	+64.5%	0.018%
2/15/2022	Cubist Systematic Strategies LLC	63,685	$0.32M	0.0%	+2,447.4%	0.030%
2/14/2022	Virtus ETF Advisers LLC	27,793	$0.14M	0.1%	+16.5%	0.013%
2/14/2022	Point72 Hong Kong Ltd	21,587	$0.11M	0.0%	+160.2%	0.010%
2/14/2022	Alliancebernstein L.P.	479,500	$2.39M	0.0%	+71.6%	0.228%
2/14/2022	Credit Suisse AG	331,347	$1.65M	0.0%	+3.8%	0.157%
2/14/2022	State Street Corp	13,300,430	$66.37M	0.0%	+21.5%	6.322%
2/14/2022	Goldman Sachs Group Inc.	1,725,324	$8.61M	0.0%	-1.8%	0.820%
2/14/2022	ETF Managers Group LLC	63,584	$0.33M	0.0%	-17.2%	0.030%
2/14/2022	Nuveen Asset Management LLC	852,838	$4.26M	0.0%	-10.1%	0.405%
2/14/2022	Barclays PLC	250,969	$1.25M	0.0%	+194.3%	0.119%
2/14/2022	GSA Capital Partners LLP	54,957	$0.27M	0.0%	+62.1%	0.026%
2/14/2022	Invesco Ltd.	79,877	$0.40M	0.0%	-13.7%	0.038%
2/11/2022	Geode Capital Management LLC	3,674,626	$18.34M	0.0%	+10.6%	1.747%
2/11/2022	Charles Schwab Investment Management Inc.	1,475,715	$7.36M	0.0%	+1.7%	0.701%
2/11/2022	Ensign Peak Advisors Inc	61,390	$0.31M	0.0%	N/A	0.029%
2/10/2022	Covestor Ltd	8,347	$42K	0.1%	N/A	0.004%
2/10/2022	JPMorgan Chase & Co.	3,797,878	$18.95M	0.0%	-7.5%	1.805%
2/10/2022	Qube Research & Technologies Ltd	86,996	$0.43M	0.0%	N/A	0.041%
2/10/2022	Rafferty Asset Management LLC	1,232,071	$6.15M	0.0%	+64.6%	0.586%
2/10/2022	Citigroup Inc.	766,725	$3.83M	0.0%	+105.9%	0.364%
2/10/2022	Teacher Retirement System of Texas	40,585	$0.20M	0.0%	+21.9%	0.019%
2/10/2022	WINTON GROUP Ltd	31,567	$0.16M	0.0%	+12.5%	0.015%
2/9/2022	Principal Financial Group Inc.	43,194	$0.22M	0.0%	-26.2%	0.021%
2/9/2022	BNP Paribas Arbitrage SA	79,409	$0.40M	0.0%	+51.2%	0.038%
2/9/2022	Dimensional Fund Advisors LP	18,000	$90K	0.0%	-42.5%	0.009%
2/9/2022	Fox Run Management L.L.C.	18,786	$94K	0.1%	+69.2%	0.009%
2/8/2022	Raymond James Financial Services Advisors Inc.	11,340	$57K	0.0%	-38.8%	0.005%
2/8/2022	Bank of America Corp DE	642,899	$3.21M	0.0%	+472.4%	0.306%
2/8/2022	CIBC Asset Management Inc	10,320	$51K	0.0%	N/A	0.005%
2/8/2022	Mirae Asset Global Investments Co. Ltd.	14,881	$75K	0.0%	N/A	0.007%
2/8/2022	ProShare Advisors LLC	74,797	$0.37M	0.0%	+4.7%	0.036%
2/8/2022	Northern Trust Corp	1,965,928	$9.81M	0.0%	-2.5%	0.934%
2/7/2022	SG Americas Securities LLC	56,821	$0.28M	0.0%	-66.7%	0.027%
2/7/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	39,948	$0.21M	0.0%	-11.4%	0.019%
2/3/2022	Cambridge Investment Research Advisors Inc.	66,341	$0.33M	0.0%	-22.4%	0.032%
2/3/2022	Advisor Group Holdings Inc.	133,376	$0.67M	0.0%	-32.0%	0.063%
2/3/2022	Daiwa Securities Group Inc.	14,590	$73K	0.0%	+92.3%	0.007%
2/3/2022	Nisa Investment Advisors LLC	7,520	$31K	0.0%	-48.6%	0.004%
2/2/2022	Oppenheimer & Co. Inc.	24,243	$0.12M	0.0%	N/A	0.012%
2/2/2022	RFG Advisory LLC	10,500	$52K	0.0%	N/A	0.005%
2/1/2022	Zurcher Kantonalbank Zurich Cantonalbank	27,399	$0.14M	0.0%	+40.5%	0.013%
2/1/2022	Defender Capital LLC.	103,038	$0.51M	0.2%	-17.9%	0.049%
2/1/2022	Qube Research & Technologies Ltd	86,996	$0.43M	0.0%	N/A	0.041%
1/28/2022	Greenwich Wealth Management LLC	28,851	$0.14M	0.0%	-17.5%	0.014%

Data available starting January 2016

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, such as head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, including recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); and Lassa fever. Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800 for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.

Today's Range

Now: $1.88

$1.77

$2.05

50 Day Range

MA: $3.04

$1.81

$3.98

52 Week Range

Now: $1.88

$1.60

$10.33

Volume

7,434,932 shs

Average Volume

6,955,482 shs

Market Capitalization

$430.60 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.8

Who are the company insiders with the largest holdings of Inovio Pharmaceuticals?: Inovio Pharmaceuticals' top insider shareholders include:
Jong Joseph Kim (CEO)
David B Weiner (Director)
David B Weiner (Director)
Peter Kies (CFO)
Jacqueline Elizabeth Shea (COO)
Laurent Humeau (Insider)
Simon X Benito (Director)
Lota S Zoth (Director)
Learn More about top insider investors at Inovio Pharmaceuticals.
Who are the major institutional investors of Inovio Pharmaceuticals?: Inovio Pharmaceuticals' top institutional shareholders include:
State Street Corp — 10.49%
BlackRock Inc. — 8.14%
Vanguard Group Inc. — 5.07%
JPMorgan Chase & Co. — 1.55%
Northern Trust Corp — 0.85%
UBS Group AG — 0.74%
Learn More about top institutional investors of Inovio Pharmaceuticals stock.
Which institutional investors are selling Inovio Pharmaceuticals stock?: Within the previous quarter, INO stock was sold by these institutional investors:
Goldman Sachs Group Inc.
Sculptor Capital LP
Sculptor Capital LP
Citigroup Inc.
JPMorgan Chase & Co.
BlackRock Inc.
IMC Chicago LLC
Royal Bank of Canada
In the previous year, company insiders that have sold Inovio Pharmaceuticals company stock include:
Jong Joseph Kim (CEO)
David B Weiner (Director)
David B Weiner (Director)
Peter Kies (CFO)
Jacqueline Elizabeth Shea (COO)
Learn More investors selling Inovio Pharmaceuticals stock.
Which institutional investors are buying Inovio Pharmaceuticals stock?: Within the previous quarter, INO stock was purchased by institutional investors including:
State Street Corp
UBS Group AG
Renaissance Technologies LLC
Triatomic Management LP
Vanguard Group Inc.
Group One Trading L.P.
Invesco Ltd.
Capital Fund Management S.A.